Analytics and Evidence
Generation Services
Powered by IHD Analytics, our analytics and
evidence generation services will be your
guide on the analytics journey.
Analytics Services
Project Implementation (Simple)
Need quick answers to high level questions? Low commitment, high reward.
Project Implementation (Complex)
Have a more complex request such as structured feasibility and assessment of fit-for-purpose data? Our team implements a single, well-defined analysis plan in IHD for you to inform go/no go decisions.
Scientific/Full Study Expertise
Let us guide you at every step of your analysis and leverage our team of experienced researchers and analysts to help you conceptualize and implement your project.
Staff Augmentation
A Panalgo expert joins your team to implement analyses in IHD for discrete project or an ongoing basis. Let us augment your staff resources to get more analyses done, more quickly.
RWD Support & Curation
Our experts work with you to get the most out of a data source, like aiding in creating an analytic dataset or understanding a new data source.
Evidence Generation Services
HEOR / RWE Teams
We bring expertise in HEOR, epidemiology, biostatistics, and data science to your real-world studies. We handle everything from study design and feasibility testing, protocol writing, study management, interpretation, reporting, through publication. Our IHD platform is 85% faster than traditional programming methods.
Epidemiology Studies
Our epidemiologists and biostatisticians can quickly generate incidence and prevalence estimates and inputs for global economic models. We can also conduct risk/benefit and post-marketing safety studies on your behalf. Our IHD platform is scalable to meet the needs of your enterprise.
Regulatory Grade Evidence
Panalgo offers a transparent, auditable, and scalable platform for generating regulatory-grade evidence, such as external control arms, RWE for label expansion and post-marketing safety surveillance. IHD has been used to expedite responses to agencies such as FDA, EMA, and PMDA (Japan).
Market Access / Commercialization Activities
As a Norstella company, we have access to a deep bench of drug commercialization and market access experts. Whether you’re looking to understand patient journey, formulary access and barriers, market segmentation, or drug launch forecast and performance, we can help.
The Panalgo Difference
- Our services and experts leverage the IHD platform for fast, flexible, and transparent analytics.
- IHD takes the guess work out of disparate data models and allows us to inform quick, data-driven decisions on feasibility, cohort design, and outcomes measurement.
- IHD has an extensive set of use cases, templates, and measures ready to go.
- Contract for a single project or dedicated support on an ongoing basis (asset, therapy area, business unit or enterprise level).
- We’re data agnostic with deep expertise in closed and open claims, EMR, laboratory, and curated datasets. Leverage our in-house data, partner data, or bring your own.
- Let us grow with you and your needs over time. Get started with Panalgo and add capabilities and tools as needed.
- Get dedicated support from our research leaders and analytic consultants, who hold a minimum of a master’s degree, and bring expertise in HEOR, epidemiology, biostatistics, and data science.
- We ensure transparency and accountability from start to finish, through direct communication with your dedicated Panalgo delivery team to comprehensive documentation and audit trails.